Koninklijke Dsm Nv Stock Today
| KDSKF Stock | USD 43.02 65.78 60.46% |
Performance9 of 100
| Odds Of DistressLess than 10
|
Koninklijke DSM is trading at 43.02 as of the 19th of April 2024. This is a -60.46 percent decrease since the beginning of the trading day. The stock's lowest day price was 43.02. Koninklijke DSM has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Koninklijke DSM NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of April 2022 and ending today, the 19th of April 2024. Click here to learn more.
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. The company has 172.97 M outstanding shares. More on Koninklijke DSM NV
Moving against Koninklijke Pink Sheet
| 0.5 | AIQUY | Air Liquide SA Earnings Call This Week | PairCorr |
| 0.5 | AIQUF | LAir Liquide SA | PairCorr |
| 0.48 | SHW | Sherwin Williams Earnings Call This Week | PairCorr |
| 0.48 | DD | Dupont De Nemours Report 7th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Koninklijke Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Koninklijke DSM's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Koninklijke DSM or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Robert Routs |
| Business Concentration | Specialty Chemicals, Basic Materials (View all Sectors) |
Koninklijke DSM NV [KDSKF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 22.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Koninklijke DSM's market, we take the total number of its shares issued and multiply it by Koninklijke DSM's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Koninklijke DSM NV classifies itself under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 172.97 M outstanding shares.
Koninklijke DSM NV has accumulated about 1.63 B in cash with 1.43 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.44.
Check Koninklijke DSM Probability Of Bankruptcy
Ownership AllocationKoninklijke DSM NV maintains a total of 172.97 Million outstanding shares. Over half of Koninklijke DSM's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Koninklijke DSM NV. Please watch out for any change in the institutional holdings of Koninklijke DSM NV as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Koninklijke Ownership Details
Koninklijke Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Koninklijke DSM jumping above the current price in 90 days from now is about 85.99%. The Koninklijke DSM NV probability density function shows the probability of Koninklijke DSM pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the pink sheet has a beta coefficient of 2.0299. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Koninklijke DSM will likely underperform. In addition to that, koninklijke DSM NV has an alpha of 3.6734, implying that it can generate a 3.67 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Koninklijke DSM to move above the current price in 90 days from now is about 85.99 (This Koninklijke DSM NV probability density function shows the probability of Koninklijke Pink Sheet to fall within a particular range of prices over 90 days) .
Koninklijke DSM NV Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Koninklijke DSM market risk premium is the additional return an investor will receive from holding Koninklijke DSM long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Koninklijke DSM. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Koninklijke DSM's alpha and beta are two of the key measurements used to evaluate Koninklijke DSM's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 12.74 | |||
| Semi Deviation | 13.56 | |||
| Standard Deviation | 32.09 | |||
| Variance | 1029.79 |
Koninklijke Stock Against Markets
Picking the right benchmark for Koninklijke DSM pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Koninklijke DSM pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Koninklijke DSM is critical whether you are bullish or bearish towards Koninklijke DSM NV at a given time. Please also check how Koninklijke DSM's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Koninklijke DSM without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Koninklijke DSM Corporate Management
Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eileen Kennedy | Member of the Supervisory Board | Profile | |
| Frits Paasschen | Independent Member of the Supervisory Board | Profile | |
| John Ramsay | Independent Member of the Supervisory Board | Profile | |
| Stefan Doboczky | Member of the Managing Board | Profile | |
| Paul Gilgen | Head Products | Profile |
How to buy Koninklijke Pink Sheet?
Before investing in Koninklijke DSM, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Koninklijke DSM. To buy Koninklijke DSM stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Koninklijke DSM. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Koninklijke DSM stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Koninklijke DSM NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Koninklijke DSM NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Koninklijke DSM NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Koninklijke DSM NV?
The danger of trading Koninklijke DSM NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Koninklijke DSM is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Koninklijke DSM. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Koninklijke DSM NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Koninklijke DSM NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Koninklijke Pink Sheet analysis
When running Koninklijke DSM's price analysis, check to measure Koninklijke DSM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke DSM is operating at the current time. Most of Koninklijke DSM's value examination focuses on studying past and present price action to predict the probability of Koninklijke DSM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke DSM's price. Additionally, you may evaluate how the addition of Koninklijke DSM to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |